Global Lung Cancer Screening Market Report 2025

Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Lung Cancer Screening Global Market Report 2025

Name: Lung Cancer Screening Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Diagnosis Type (Low Dose Spiral Computed Tomography Scan, Chest-X-Ray), By Cancer Type (Non-Small Cell Lung Cancer, Small Cell Lung Cancer), By Age Group (50 And Older, Below 50), By End-User (Hospitals And Clinics, Diagnostic Centers, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Lung Cancer Screening Market Overview

• Lung Cancer Screening market size has reached to $3.03 billion in 2024

• Expected to grow to $4.79 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%

• Growth Driver: Rise In Smoking Rates Fueling The Growth Of The Market Due To Increasing Tobacco Accessibility And Health Awareness

• Market Trend: Innovations In Artificial Intelligence (AI) Technology Enhance Early Detection And Diagnostic Precision In Chest Imaging

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Lung Cancer Screening Market?

Lung cancer screening is a preventive approach aimed at identifying cancer in the lungs at an early stage, often before any noticeable symptoms develop. It focuses on individuals who may have a higher risk due to specific health or lifestyle factors. The purpose of this process is to detect any unusual changes or growths in the lung tissue early, which can help improve the chances of effective treatment and reduce the overall impact of the disease.

The main diagnosis types of lung cancer screening include low-dose spiral computed tomography scans and chest X-rays. Low-dose spiral computed tomography scan refers to an imaging technique that uses low-dose radiation to create detailed cross-sectional images of the lungs, enabling early detection of lung abnormalities with high sensitivity. It is used for different cancer types, such as non-small cell lung cancer and small cell lung cancer, for different age groups, including 50 and older and below 50. It is used by several end-users, including hospitals and clinics, diagnostic centers, and others.

Lung Cancer Screening Market Size and growth rate 2025 to 2029: Graph

What Is The Lung Cancer Screening Market Size 2025 And Growth Rate?

What Is The Lung Cancer Screening Market Growth Forecast?

The lung cancer screening market size is expected to see strong growth in the next few years. It will grow to $4.79 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to the growing burden of air pollution and occupational exposure, rising clinical evidence supporting early screening benefits, growing availability of insurance coverage, increasing urbanization and lifestyle changes, and rising investments in radiology infrastructure. Major trends in the forecast period include integration of cloud-based imaging platforms, developments in radiomics and image analytics, advancements in portable and point-of-care imaging devices, integration of decision support systems in radiology workflows, and advancements in non-invasive biomarker-based screening.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Lung Cancer Screening Market Segmented?

1) By Diagnosis Type: Low Dose Spiral Computed Tomography Scan, Chest-X-Ray

2) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer

3) By Age Group: 50 And Older, Below 50

4) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users

Subsegments:

1) By Low Dose Spiral Computed Tomography Scan: Screening, Diagnostic, Follow-Up

2) By Chest X-Ray: Posterior Anterior, Lateral, Portable

What Is Driving The Lung Cancer Screening Market? Rise In Smoking Rates Fueling The Growth Of The Market Due To Increasing Tobacco Accessibility And Health Awareness

The rising smoking rates are expected to propel the growth of the lung cancer screening market going forward. Smoking is the practice of breathing in smoke from burning substances, typically tobacco, through the mouth and lungs. The rise in smoking rates is due to increasing stress levels, leading more people to turn to smoking as a coping mechanism. Lung cancer screening is helpful in addressing rising smoking rates by enabling early detection of smoking-related health risks, which can motivate individuals to quit and support broader public health efforts in reducing tobacco use. For instance, in September 2023, according to the Office for National Statistics, a UK-based government agency, in Great Britain, about 4.5 million adults, or 8.7% of the population, reported using e-cigarettes either daily or occasionally in 2022, reflecting an increase from 7.7% in 2021. Therefore, the rising smoking rates are driving the growth of the lung cancer screening industry.

Who Are The Major Players In The Global Lung Cancer Screening Market?

Major companies operating in the lung cancer screening market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, AstraZeneca Plc, Abbott Laboratories Inc., Canon Inc., Medtronic Plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Quest Diagnostics Incorporated, Agilent Technologies Inc., Shimadzu Corporation, NeoGenomics Laboratories Inc., Freenome Holdings Inc., Biodesix Inc., Lunit Inc., Infervision, Riverain Technologies, VisionGate, and Delfi Diagnostics Inc.

What Are The Key Trends Of The Global Lung Cancer Screening Market? Innovations In Artificial Intelligence (AI) Technology Enhance Early Detection And Diagnostic Precision In Chest Imaging

Major companies operating in the lung cancer screening market are focusing on developing advanced solutions, such as normal flagging, to enhance diagnostic accuracy, reduce false positives, and improve early detection of cancerous nodules. Normal flagging refers to a technological feature in lung cancer screening that automatically identifies and flags scans with no abnormal findings, helping prioritize cases that need further review. For instance, in May 2025, Lunit Inc., a South Korea-based medical technology company, launched INSIGHT CXR4, its next-generation artificial intelligence (AI)-powered chest X-ray analysis solution, which is now CE MDR-certified for deployment across Europe. Designed to assist radiologists with improved diagnostic accuracy and workflow efficiency, the solution detects 12 chest abnormalities, including lung nodules, pneumonia, and acute bone fractures, and introduces features such as current-prior image comparison to support early disease detection and clinical decision-making.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Lung Cancer Screening Market? Intelerad Expands Imaging Solutions With Acquisition Of PenRad Technologies

In August 2022, Intelerad Medical Systems Inc., a US-based medical imaging software provider company, acquired PenRad Technologies, Inc. for an undisclosed amount. Through this acquisition, Intelerad aims to expand its product offerings in mammography and lung cancer screening, enhancing workflow efficiency for radiologists and improving patient health outcomes. PenRad Technologies Inc. is a US-based provider of lung cancer screening software.

What Is The Regional Outlook For The Global Lung Cancer Screening Market?

North America was the largest region in the lung cancer screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Lung Cancer Screening Market?

The lung cancer screening market includes revenues earned by entities by providing services such as radiology interpretation, diagnostic follow-up procedures, patient risk assessment, and telehealth consultation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Lung Cancer Screening Industry?

The lung cancer screening market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the lung cancer screening industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Lung Cancer Screening Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$3.33 billion
Revenue Forecast In 2034	$4.79 billion
Growth Rate	CAGR of 9.5% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Diagnosis Type, Cancer Type, Age Group, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, AstraZeneca Plc, Abbott Laboratories Inc., Canon Inc., Medtronic Plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Quest Diagnostics Incorporated, Agilent Technologies Inc., Shimadzu Corporation, NeoGenomics Laboratories Inc., Freenome Holdings Inc., Biodesix Inc., Lunit Inc., Infervision, Riverain Technologies, VisionGate, and Delfi Diagnostics Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Lung Cancer Screening Market Characteristics

3. Lung Cancer Screening Market Trends And Strategies

4. Lung Cancer Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Lung Cancer Screening Growth Analysis And Strategic Analysis Framework

5.1. Global Lung Cancer Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Lung Cancer Screening Market Growth Rate Analysis

5.4. Global Lung Cancer Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Lung Cancer Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Lung Cancer Screening Total Addressable Market (TAM)

6. Lung Cancer Screening Market Segmentation

6.1. Global Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Low Dose Spiral Computed Tomography Scan

Chest-X-Ray

6.2. Global Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Non-Small Cell Lung Cancer (NSCLC)

Small Cell Lung Cancer

6.3. Global Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

50 And Older

Below 50

6.4. Global Lung Cancer Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Diagnostic Centers

Other End-Users

6.5. Global Lung Cancer Screening Market, Sub-Segmentation Of Low Dose Spiral Computed Tomography Scan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Screening

Diagnostic

Follow-Up

6.6. Global Lung Cancer Screening Market, Sub-Segmentation Of Chest X-Ray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Posterior Anterior

Lateral

Portable

7. Lung Cancer Screening Market Regional And Country Analysis

7.1. Global Lung Cancer Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Lung Cancer Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lung Cancer Screening Market

8.1. Asia-Pacific Lung Cancer Screening Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lung Cancer Screening Market

9.1. China Lung Cancer Screening Market Overview

9.2. China Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lung Cancer Screening Market

10.1. India Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lung Cancer Screening Market

11.1. Japan Lung Cancer Screening Market Overview

11.2. Japan Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lung Cancer Screening Market

12.1. Australia Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lung Cancer Screening Market

13.1. Indonesia Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lung Cancer Screening Market

14.1. South Korea Lung Cancer Screening Market Overview

14.2. South Korea Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lung Cancer Screening Market

15.1. Western Europe Lung Cancer Screening Market Overview

15.2. Western Europe Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lung Cancer Screening Market

16.1. UK Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lung Cancer Screening Market

17.1. Germany Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lung Cancer Screening Market

18.1. France Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lung Cancer Screening Market

19.1. Italy Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lung Cancer Screening Market

20.1. Spain Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lung Cancer Screening Market

21.1. Eastern Europe Lung Cancer Screening Market Overview

21.2. Eastern Europe Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lung Cancer Screening Market

22.1. Russia Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lung Cancer Screening Market

23.1. North America Lung Cancer Screening Market Overview

23.2. North America Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lung Cancer Screening Market

24.1. USA Lung Cancer Screening Market Overview

24.2. USA Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lung Cancer Screening Market

25.1. Canada Lung Cancer Screening Market Overview

25.2. Canada Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lung Cancer Screening Market

26.1. South America Lung Cancer Screening Market Overview

26.2. South America Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lung Cancer Screening Market

27.1. Brazil Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lung Cancer Screening Market

28.1. Middle East Lung Cancer Screening Market Overview

28.2. Middle East Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lung Cancer Screening Market

29.1. Africa Lung Cancer Screening Market Overview

29.2. Africa Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lung Cancer Screening Market Competitive Landscape And Company Profiles

30.1. Lung Cancer Screening Market Competitive Landscape

30.2. Lung Cancer Screening Market Company Profiles

30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Canon Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Lung Cancer Screening Market Other Major And Innovative Companies

31.1. Medtronic Plc

31.2. Siemens Healthineers AG

31.3. Koninklijke Philips N.V.

31.4. GE Healthcare Technologies Inc.

31.5. Quest Diagnostics Incorporated

31.6. Agilent Technologies Inc.

31.7. Shimadzu Corporation

31.8. NeoGenomics Laboratories Inc.

31.9. Freenome Holdings Inc.

31.10. Biodesix Inc.

31.11. Lunit Inc.

31.12. Infervision

31.13. Riverain Technologies

31.14. VisionGate

31.15. Delfi Diagnostics Inc.

32. Global Lung Cancer Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lung Cancer Screening Market

34. Recent Developments In The Lung Cancer Screening Market

35. Lung Cancer Screening Market High Potential Countries, Segments and Strategies

35.1 Lung Cancer Screening Market In 2029 - Countries Offering Most New Opportunities

35.2 Lung Cancer Screening Market In 2029 - Segments Offering Most New Opportunities

35.3 Lung Cancer Screening Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Lung Cancer Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Lung Cancer Screening Market, Sub-Segmentation Of Low Dose Spiral Computed Tomography Scan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Lung Cancer Screening Market, Sub-Segmentation Of Chest X-Ray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Lung Cancer Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Lung Cancer Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Johnson & Johnson Services Inc. Financial Performance

Table 78: F. Hoffmann-La Roche AG Financial Performance

Table 79: AstraZeneca Plc Financial Performance

Table 80: Abbott Laboratories Inc. Financial Performance

Table 81: Canon Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Lung Cancer Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Lung Cancer Screening Market, Sub-Segmentation Of Low Dose Spiral Computed Tomography Scan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Lung Cancer Screening Market, Sub-Segmentation Of Chest X-Ray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Lung Cancer Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Lung Cancer Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Johnson & Johnson Services Inc. Financial Performance

Figure 78: F. Hoffmann-La Roche AG Financial Performance

Figure 79: AstraZeneca Plc Financial Performance

Figure 80: Abbott Laboratories Inc. Financial Performance

Figure 81: Canon Inc. Financial Performance

From Insight to Impact: Strategic Growth Mapping in the HER2-Positive Breast Cancer Market

Hospital And Nursing Home Probiotics Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

Next-Gen Implantable Cardioverter Defibrillators (ICDs) : Market Forecast, Transformation, and Long-Term Trajectories

Indwelling Catheters Growth Trajectory: Key Forecasts and Strategic Insights

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Financial Fraud Detection Software Global Market Report 2025 – By Component (Solution, Service), By Fraud Type ( Money Laundering, Identity Theft, Debit And Credit Card Frauds, Claim Frauds, Transfer Frauds, Other Fraud ...

Payment Monitoring Global Market Report 2025 – By Type (Case Management, Dashboard And Reporting, KYC Or Customer Onboarding, Watch List Screening), By Deployment (Cloud, On-premise), By Organization Size (Large Enterpri...

eCommerce Fraud Detection And Prevention Global Market Report 2025 – By Type( Cloud Based, On-Premise), By Fraud Type( Card Testing, Credit Card Fraud, Friendly Fraud, Identity Theft, Merchant Fraud, Phishing, Refund Fra...

Fraud Hunters Global Market Report 2025 – By Type of Fraud (Financial Statement Fraud, Healthcare, Insurance and Banking Fraud, Consumer Fraud, Intellectual Property Fraud, Other Types of Fraud), By Organization Size (SM...

Insurance Fraud Detection Global Market Report 2025 – By Deployment Type (On-Premises, Cloud), By Component (Solution, Services), By Organization Size (Small And Medium-Sized Enterprises (SMEs), Large Enterprises), By Ap...

Digital Payments Global Market Report 2025 – By Mode Of Payment (Point Of Sale, Online Sale), By End-User Industry (Retail, Banking And Financial Service, Telecommunication, Government, Transportation, Others), By Deploy...

Payment Security Global Market Report 2025 – By Solution (Encryption, Tokenization, Fraud Detection And Prevention), By Services (Integration Services, Support Services, Consulting Services), By Organization Size (Large ...

Frequently Asked Questions

What is the definition of the Lung Cancer Screening market?

How will the Lung Cancer Screening market drivers and restraints affect the market dynamics? What forces will shape the Lung Cancer Screening industry going forward?

The market major growth driver - Rise In Smoking Rates Fueling The Growth Of The Market Due To Increasing Tobacco Accessibility And Health Awareness. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Lung Cancer Screening market?

The lung cancer screening market size has grown strongly in recent years. It will grow from $3.03 billion in 2024 to $3.33 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to rising prevalence of tobacco consumption, growing awareness about early cancer detection, increasing government initiatives and screening programs, rising geriatric population, and increasing penetration of private diagnostic centers. The lung cancer screening market size is expected to see strong growth in the next few years. It will grow to $4.79 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to the growing burden of air pollution and occupational exposure, rising clinical evidence supporting early screening benefits, growing availability of insurance coverage, increasing urbanization and lifestyle changes, and rising investments in radiology infrastructure. Major trends in the forecast period include integration of cloud-based imaging platforms, developments in radiomics and image analytics, advancements in portable and point-of-care imaging devices, integration of decision support systems in radiology workflows, and advancements in non-invasive biomarker-based screening. For further insights on this market, request a sample here

How is the Lung Cancer Screening market segmented?

The lung cancer screening market covered in this report is segmented
1) By Diagnosis Type: Low Dose Spiral Computed Tomography Scan, Chest-X-Ray
2) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer
3) By Age Group: 50 And Older, Below 50
4) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users Subsegments:
1) By Low Dose Spiral Computed Tomography Scan: Screening, Diagnostic, Follow-Up
2) By Chest X-Ray: Posterior Anterior, Lateral, Portable For further insights on this market, request a sample here

Which region has the largest share of the Lung Cancer Screening market? What are the other regions covered in the report?

North America was the largest region in the lung cancer screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Lung Cancer Screening market?

What are the key trends in the Lung Cancer Screening market?

Major trends in this market include Innovations In Artificial Intelligence (AI) Technology Enhance Early Detection And Diagnostic Precision In Chest Imaging. For further insights on this market, request a sample here.